【直播预告】中美AI医疗的机遇与挑战：技术前沿、法律边界与未来展望

▲点击蓝色字体关注我们，文末添加小助理，领取直播福利！

点击预约，进入视频号学习更多课程

活动背景

···

人工智能（AI）正以前所未有的速度和深度革新全球医疗健康领域。从辅助诊断到新药研发，AI的潜力令人振奋。然而，随之而来的数据隐私保护、算法公平性、责任归属等法律和伦理挑战也日益凸显。各国在推动AI医疗发展的同时，如何构建适应新时代的法律框架，成为亟待解答的关键问题。

Artificial intelligence (AI) is revolutionizing the global healthcare sector with unprecedented speed and depth. From assistive diagnostics to new drug discovery, AI's potential is exhilarating.However, accompanying legal and ethical challenges such as data privacy protection, algorithmic fairness, and liability attribution are becoming increasingly prominent. As countries advance AI healthcare development, how to construct a legal framework adaptable to the new era has become a critical question demanding urgent answers.

本次直播特邀享誉全球的医学专家、西奈山医疗系统呼吸内科、危重症医学和睡眠医学系统科主任查尔斯·A·鲍威尔教授（Charles A. Powell, MD, MBA），与上海小度律师事务所AI法律交叉领域专家卢叶婷老师，共同探讨中美两国在人工智能医学领域的现状、差异及未来走向。

This webinar specially invites world-renowned medical expert, Charles A. Powell, MD, MBA, System Chief of Pulmonary, Critical Care, and Sleep Medicine at Mount Sinai Health System, and Lu Yetting, an AI legal interdisciplinary expert from Shanghai Shalldo Law Firm, to jointly explore the current status, differences, and future trends of AI in medicine in both China and the United States.

分享主题

本次直播，查尔斯·A·鲍威尔教授与卢叶婷老师将结合各自的专业经验，为您带来「中美AI医疗的机遇与挑战：技术前沿、法律边界与未来展望」的深度分享。

In this webinar, Professor Charles A. Powell and Lawyer Lu Yetting will combine their respective professional experiences to bring you an in-depth presentation on "Opportunities and Challenges in US-China AI Healthcare: Technological Frontiers, Legal Boundaries, and Future Outlook."

主要内容

本次直播，将深入剖析： This webinar will delve into:

一、中国AI医疗的蓬勃发展与技术突破： 我们将从技术角度出发，全面梳理中国人工智能医学的最新进展、关键应用场景和面临的挑战，并由此引申出中国相关法律法规的演进与实践。I. The Flourishing Development and Technological Breakthroughs in China's AI Healthcare: We will, from a technological perspective, comprehensively review the latest advancements, key application scenarios, and challenges faced by AI in medicine in China, and subsequently deduce the evolution and practice of relevant Chinese laws and regulations.

二、美国AI医疗的创新实践与鲍威尔教授的真知灼见： 鲍威尔教授将分享他在美国人工智能医学项目中的宝贵经验和独到见解，揭示美国AI医疗在临床实践中的主要应用领域。 II. Innovative Practices in US AI Healthcare and Professor Powell's Insights: Professor Powell will share his valuable experience and unique insights from AI medical projects in the United States, revealing the primary application areas of US AI healthcare in clinical practice.

三、中美医疗体系下的AI融合之道： 两国医疗体系的迥异，如何影响AI在医疗领域的落地？我们将对比分析AI在美国医疗体系中的具体应用，以及其与中国模式的异同。 III. The Path to AI Integration within US-China Healthcare Systems: How do the distinct healthcare systems of the two countries impact the implementation of AI in healthcare? We will comparatively analyze specific AI applications within the US healthcare system and their similarities and differences with the Chinese model.

四、数据驱动下的AI医学训练： 中美两国在医学AI训练中主要使用哪些数据？数据来源、处理方式有何区别？这些差异对AI模型的效果和可靠性有何影响？ IV. Data-Driven AI Medical Training: What primary types of data are utilized in medical AI training in China and the United States? What are the differences in data sources and processing methods? How do these disparities affect the performance and reliability of AI models?

五、隐私保护的法律壁垒与AI应用： 美国严格的医学隐私相关法律（如HIPAA）对AI医疗的发展和数据使用带来哪些深远影响？中国在个人健康数据保护方面有哪些探索和实践？法律法规如何平衡创新与保护？ V. Legal Barriers to Privacy Protection and AI Applications: What profound impacts do stringent medical privacy-related laws in the United States (e.g., HIPAA) have on the development of AI healthcare and data utilization? What explorations and practices has China undertaken in personal health data protection? How do laws and regulations balance innovation and protection?

课程安排

时间：2025年5月29日晚上20:00

Time: May 29, 2025, 8:00 PM (Beijing Time)

对象：医疗从业者、法律人士（律师、法务）、科技开发者、研究人员及其他对话题感兴趣的社会人士法务、其他对话题感兴趣的社会人士

Target Audience：Medical practitioners，legal professionals (lawyers,in-house counsel)，technology developers，researchers，and other members of society interested in the topic.

课程形式：在线直播 Course Format：Online Webinar

扫描二维码预约课程 Scan QR Code to Register

分享嘉宾：查尔斯·A·鲍威尔教授（Charles A. Powell, MD, MBA） - 西奈山医疗系统呼吸内科、危重症医学和睡眠医学系统科主任 Charles A. Powell, MD, MBA - System Chief of Pulmonary, Critical Care, and Sleep Medicine, Mount Sinai Health System

卢叶婷 - 上海小度律师事务所AI法律交叉领域专家 Lu Yetting - AI Legal Interdisciplinary Expert, Shanghai Shalldo Law Firm

嘉宾介绍

查尔斯·A·鲍威尔

查尔斯·A·鲍威尔，医学博士，工商管理硕士，现任西奈山医疗系统医学教授兼呼吸内科、危重症医学和睡眠医学系统科主任。鲍威尔博士在宾夕法尼亚大学获得经济学学士学位，之后在芝加哥大学获得医学学位。他曾在哥伦比亚大学接受内科培训，并在波士顿大学接受肺部和危重症医学培训。鲍威尔博士现任西奈山医院医生教员实践区域医疗总监以及西奈山呼吸研究所有限责任公司首席执行官，该研究所汇集了诊断和治疗各种呼吸系统疾病和肺部疾病（包括哮喘、肺癌、慢性阻塞性肺疾病、间质性肺病和支气管扩张）的领先专家。他曾任弗莱施纳学会主席、ATS胸腔肿瘤学大会创始主席，并在国际呼吸系统疾病学会担任领导职务。鲍威尔博士获得美国国立卫生研究院（NIH）的资助，已发表150多篇文章，并指导一个由NIH资助的转化科学实验室，该实验室研究肺癌的基因组学。他是药物性肺损伤诊断和管理方面的国际专家，尤其擅长治疗接受抗体偶联药物和免疫疗法等晚期癌症药物的患者。他还指导研究项目，致力于应用机器学习和人工智能来推动呼吸系统疾病的诊断和治疗。

Charles A. Powell, MD, MBA
Florette and Ernst Rosenfeld and Joseph Solomon Professor of Medicine

Icahn School of Medicine at Mount Sinai

Mount Sinai Health System, New York, NY

Charles A Powell, MD, MBA, is Professor of Medicine and System Division Chief for Pulmonary, Critical Care, and Sleep Medicine at the Mount Sinai Health System. Dr. Powell earned his bachelor’s degree in economics from the University of Pennsylvania before completing his medical degree at the University of Chicago. He trained in Internal Medicine at Columbia University and in Pulmonary and Critical Care Medicine at Boston University. Dr. Powell is Regional Medical Director of the Mount Sinai Hospital Doctors Faculty Practice and CEO of the Mount Sinai Respiratory Institute LLC, which brings together leading expertise in diagnosing and treating all forms of respiratory illness and lung disease, including asthma, lung cancer, chronic obstructive pulmonary disease, interstitial lung disease, and bronchiectasis. He is past-President of the Fleischner Society, founding Chair of the ATS Thoracic Oncology Assembly, and holds leadership roles in the International Society of Respiratory Disease. Dr. Powell is funded by the National Institutes of Health (NIH), has published over 150 articles, and directs an NIH-funded translational sciences laboratory that examines the genomics of lung cancer. He is an international expert in the diagnosis and management of drug induced lung injury in patients treated with advanced cancer medications such as antibody drug conjugates and immunotherapy. He also directs research programs focused on applications of machine learning and artificial intelligence to advance the diagnosis and treatment of respiratory diseases.

卢叶婷-上海小度律师事务所律师

卢叶婷目前从事于互联网、人工智能等科技领域的法律服务，方向在公司治理、争议解决、投融资。拥有理工科和法律复合背景，具备技术与法律的敏感度，致力于帮助企业在AI时代长远发展。

Lu yeting specializes in providing legal services for the internet and artificial intelligence sectors, focusing on corporate governance, dispute resolution, and investment & financing. With a dual background in STEM and Law, she possesses a keen sensitivity to both technology and legal matters, and I am dedicated to helping businesses achieve long-term growth in the AI era.

扫描海报二维码，进入视频号，预约直播 ✔

一键预约

本期福利

为帮助读者更好地了解直播内容，本期iLaw携手嘉宾团队精心准备了相关福利资料。如有需要，请扫码添加小助理圈圈，并转发本篇文章至对话框，即可免费领取⬇

1.《卫生健康行业人工智能应用场景参考指引》

「2025人工智能指数报告」

■

点亮在看👇